JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Personal experiences with replantation of fingers in the zone 1 area (fingertips)].

After an amputation of a finger in zone I (up to the root of the nail) replantation with vascular anastomoses is mostly not possible. Therefore, we started to replant such amputates as a composite graft with the same medication as in replantation surgery: 500 cc low molecular dextran for 7 days, 330 mg acetyl-salicylic acid and 75 mg dipyridamol for 14 days usually. In 12 patients we replanted 16 finger- or thumbtips with 12 survivals. We had the best results in clean cut amputations. Concerning the late results we achieved always good sensibility and no evidence of any circulatory disturbance by about 6 months. The replants were useful and not painful. Occasionally we noticed some atrophy. The nail growth was nearly normal if the nail was not destroyed or severely damaged.

Full text links

Management of Latent Tuberculosis Infection.JAMA 2023 January 20
Misdiagnosis in the Emergency Department: Time for a System Solution.JAMA 2023 January 28

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app